BioAdaptives, Inc. (BDPT) Fair Value 2026

BDPT · Packaged Foods ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.0 /10

32 fundamental signals · 1 models active

Value Trap Risk

WARN (47/100)

Quick Summary — As of 2026-08-27, BioAdaptives, Inc. (BDPT) trades at $0.00. QOC: 4.0/10. Value Trap Risk: 47/100 (WARN). 1/13 models active.

Key Facts

Ticker
BDPT
Price
$0.00
Quality Score
4.0/10
Value Trap Risk
47/100
Models Active
1/13
Last Updated
Strength: PWERM suggests +80.8% upside with 31% confidence
Risk: Value Trap score of 47 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give BDPT?

1 Intrinsic Value Models vs. Current Price ($0.00)

Core Models (Unlocked)
Model Fair Value Upside
Option-Based · Medium Conviction
 $0.00 +80.8%

All Models Active

All 1 models are displayed above.

What Is BioAdaptives, Inc. (BDPT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, BioAdaptives, Inc.'s intrinsic value is estimated at a median fair value of $0.00. At a current market price of $0.00, 1 of 1 active valuation models identify upside potential, projecting a median implied return of +80.8%.

What Do the Models Say About BDPT?

1 of 13 models are currently active for BDPT. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does BDPT Rank in Packaged Foods?

Among 81 Packaged Foods stocks, BDPT ranks #72 by Quality of Company score. CirclFi's QOC score of 4.0/10 evaluates 32 fundamental signals. A score of 4.0 signals below-average fundamentals.

See all Most Undervalued Packaged Foods Stocks →

The Packaged Foods sector introduces analytical considerations specific to retail business businesses. For BioAdaptives, Inc., metrics like same-store sales growth (comps) provide important context that general-purpose valuation models may underweight.

Is BDPT a Value Trap?

CirclFi's Value Trap algorithm assigns BDPT a score of 47/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for BioAdaptives, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, BioAdaptives, Inc. scores 4.0 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every BDPT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across BDPT's 1 active models, average confidence is 31%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy BioAdaptives, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Packaged Foods Stocks Should You Also Analyze?

11 related Packaged Foods stocks with 13-model coverage

ARRTArtisan Consumer Goods, Inc.QOC 4.1OFRMOnce Upon A Farm, PBCQOC 3.7BFNHBioForce Nanosciences Holdings, Inc.QOC 4.4GLUCGlucose Health, Inc.QOC 3.7HIGRHi-Great Group Holding CompanyQOC 4.4BSFCBlue Star Foods Corp.QOC 3.3FLOFlowers Foods, Inc.QOC 8.3LSFLaird Superfood, Inc.QOC 6.9RKDAArcadia Biosciences, Inc.QOC 5.4PPCPilgrim's Pride CorporationQOC 9.0JJSFJ&J Snack Foods Corp.QOC 8.9

Read investment analysis: ARRT · OFRM · BFNH · GLUC · HIGR · BSFC · FLO · LSF · RKDA · PPC · JJSF

Which Other Stocks Have a Similar Quality Score to BDPT?

7 companies across all industries closest to BDPT’s Quality of Company score of 4.0/10.

PPCBPropanc Biopharma, Inc.QOC 4.0MBIOMustang Bio, Inc.QOC 4.0VIIQVIIQQOC 4.0BLNEBeeline Holdings, Inc.QOC 4.0AIXCAIxCrypto Holdings, Inc.QOC 4.0MDCXMedicus Pharma Ltd.QOC 4.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: PPCB · MBIO · VIIQ · BLNE · AIXC · MDCX · NVDA

Where Does BDPT Sit in CirclFi's Packaged Foods Rankings?

BDPT is ranked against every other Packaged Foods stock CirclFi covers in each of these screens.

See all Packaged Foods stocks ranked →

What Else Do Investors Ask About BioAdaptives, Inc.’s Valuation?

What is BioAdaptives, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for BioAdaptives, Inc. (BDPT). The Quality of Company score is 4.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is BDPT overvalued or undervalued right now?

At $0.00, 1 of 1 active models suggest BDPT may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits BioAdaptives, Inc.'s business model in Packaged Foods.

What does a Quality of Company score of 4.0 mean for BDPT?

BioAdaptives, Inc.'s QOC of 4.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on BDPT?

CirclFi analyzes BDPT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is BDPT a value trap in 2026?

BioAdaptives, Inc.'s Value Trap score is 47/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns BioAdaptives, Inc. (BDPT) a Quality of Company score of 4.0/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/BDPT/ · Methodology
Primary sources for this BDPT valuation
  • Financial statements: BioAdaptives, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001575142) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for BDPT as of ; valuations recomputed .